Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4955140013 | Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4955141012 | Valproate sodium 200 mg and valproic acid 87 mg prolonged-release oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5171157015 | Product containing precisely sodium valproate 200 milligram and valproic acid 87 milligram/1 each prolonged-release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet | Has manufactured dose form | Prolonged-release oral tablet | true | Inferred relationship | Some | ||
| Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet | Plays role | Anticonvulsant therapeutic role (role) | true | Inferred relationship | Some | ||
| Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet | Has precise active ingredient | Valproic acid (substance) | true | Inferred relationship | Some | 1 | |
| Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet | Has basis of strength substance (attribute) | Valproic acid (substance) | true | Inferred relationship | Some | 1 | |
| Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet | Has precise active ingredient | Sodium valproate | true | Inferred relationship | Some | 2 | |
| Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet | Has basis of strength substance (attribute) | Sodium valproate | true | Inferred relationship | Some | 2 | |
| Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet | Is a | Sodium valproate 200 mg prolonged-release oral tablet | false | Inferred relationship | Some | ||
| Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet | Is a | Valproic acid only product in oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR